Related Experiment Video
Updated: May 15, 2026

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader
Published on: May 24, 2024
Thrombin-mediated proteoglycan synthesis utilizes both protein-tyrosine kinase and serine/threonine kinase receptor
Micah L Burch1, Robel Getachew, Narin Osman
1Diabetes Complications Laboratory, Royal Melbourne Institute of Technology University, Bundoora, Victoria 3004, Australia.
Abstract:
G protein-coupled receptor signaling is mediated by three main mechanisms of action; these are the classical pathway, β-arrestin scaffold signaling, and the transactivation of protein-tyrosine kinase receptors such as those for EGF and PDGF. Recently, it has been demonstrated that G protein-coupled receptors can also mediate signals via transactivation of serine/threonine kinase receptors, most notably the transforming growth factor-β receptor family. Atherosclerosis is characterized by the development of lipid-laden plaques in blood vessel walls. Initiation of plaque development occurs via low density lipoprotein retention in the neointima of vessels due to binding with modified proteoglycans secreted by vascular smooth muscle cells. Here we show that transactivation of protein-tyrosine kinase receptors is mediated by matrix metalloproteinase triple membrane bypass signaling. In contrast, serine/threonine kinase receptor transactivation is mediated by a cytoskeletal rearrangement-Rho kinase-integrin system, and both protein-tyrosine kinase and serine/threonine kinase receptor transactivation concomitantly account for the total proteoglycan synthesis stimulated by thrombin in vascular smooth muscle. This work provides evidence of thrombin-mediated proteoglycan synthesis and paves the way for a potential therapeutic target for plaque development and atherosclerosis.
Insights
Thrombin stimulates vascular smooth muscle cells to synthesize proteoglycans, a key factor in atherosclerosis plaque development. This study reveals novel signaling pathways involved in this process, offering potential therapeutic targets.
Area of Science:
- Cellular signaling pathways
- Vascular biology
- Atherosclerosis research
Background:
- G protein-coupled receptors (GPCRs) signal through classical pathways, β-arrestin scaffolding, and transactivation of receptor tyrosine kinases (e.g., EGF, PDGF).
- GPCRs can also activate serine/threonine kinase receptors, including the transforming growth factor-β receptor family.
- Atherosclerosis involves lipid-laden plaque formation in blood vessels, initiated by low-density lipoprotein retention mediated by proteoglycans.
Purpose of the Study:
- To elucidate the mechanisms by which GPCRs, specifically thrombin signaling, stimulate proteoglycan synthesis in vascular smooth muscle cells.
- To investigate the distinct pathways involved in protein-tyrosine kinase and serine/threonine kinase receptor transactivation.
- To establish a link between these signaling pathways and the development of atherosclerotic plaques.
Main Methods:
- Investigated thrombin-induced signaling in vascular smooth muscle cells.
- Differentiated mechanisms of protein-tyrosine kinase receptor transactivation (matrix metalloproteinase signaling).
- Identified the cytoskeletal rearrangement-Rho kinase-integrin system in serine/threonine kinase receptor transactivation.
Main Results:
- Thrombin-mediated protein-tyrosine kinase receptor transactivation occurs via matrix metalloproteinase signaling.
- Serine/threonine kinase receptor transactivation is mediated by a cytoskeletal rearrangement-Rho kinase-integrin pathway.
- Both pathways concurrently drive proteoglycan synthesis stimulated by thrombin in vascular smooth muscle cells.
Conclusions:
- Thrombin significantly stimulates proteoglycan synthesis in vascular smooth muscle cells through distinct kinase receptor transactivation pathways.
- These findings provide crucial insights into the molecular mechanisms underlying thrombin's role in atherosclerosis.
- The identified pathways represent potential therapeutic targets for mitigating plaque development and treating atherosclerosis.
More Related Videos
11:38Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
06:14Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function
Published on: June 11, 2017
Related Concept Videos
TGF - β Signaling Pathway
Receptor Tyrosine Kinases
Amplifying Signals via Enzymatic Cascade
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Intracellular Signaling Affects Focal Adhesions
Some...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include: